Prudential Financial
OCUL icon

Prudential Financial’s Ocular Therapeutix OCUL Stock Holding History

Prudential Financial’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Buy
29,270
+18,060
+161% +$172K ﹤0.01% 2078
2025
Q4 		$136K Sell
11,210
-7,555
-40% -$91.8K ﹤0.01% 2102
2025
Q3 		$219K Buy
18,765
+65
+0.3% +$777 ﹤0.01% 2195
2025
Q2 		$174K Buy
18,700
+6,855
+58% +$53.7K ﹤0.01% 2233
2025
Q1 		$86.8K Buy
11,845
+320
+3% +$2.46K ﹤0.01% 2145
2024
Q4 		$98.4K Hold
11,525
– – ﹤0.01% 2149
2024
Q3 		$100K Sell
11,525
-70
-0.6% -$577 ﹤0.01% 2577
2024
Q2 		$79.3K Sell
11,595
-3,410
-23% -$21.1K ﹤0.01% 2565
2024
Q1 		$137K Buy
+15,005
New +$106K ﹤0.01% 2503

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return